跳至主要内容
临床试验/NCT06429514
NCT06429514已完成不适用

Based on the Theory of Gut-brain Axis, the Intervention Effect and Related Mechanism of Ganoderma Lucidum Spore Powder on Depressive Symptoms in Patients With Thyroid Cancer Were Investigated

Ling Zhiqiang1 个研究点 分布在 1 个国家目标入组 298 人开始时间: 2023年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
298
试验地点
1
主要终点
Depression symptoms relieved

研究概览

简要总结

To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.

详细描述

After being informed of the study and potential risks, all patients who gave written informed consent were enrolled. A total of 300 eligible patients were randomly assigned in a double-blind manner and divided into experimental group and control group at a ratio of 2 : 1. The subjects were given oral test drugs ( Ganoderma lucidum spore powder or placebo ) 4g per day for 90 days from the first day after enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •patients with depressive symptoms after surgery for papillary thyroid carcinoma in the outpatient department of Zhejiang Cancer Hospital
  • •Han nationality
  • •No previous depression and other mental diseases
  • •18-80 years old
  • •BMI 19 ~ 24

排除标准

  • •suffering from other diseases of the intestinal system
  • •Gastrointestinal surgery was performed before intervention
  • •Including patients with other malignant tumors, who need chemotherapy, radiotherapy, biological therapy or traditional Chinese medicine treatment received antibiotics or microecological modulators within 3 months before the intervention
  • •Acute intestinal obstruction
  • •Patients with severe depressive symptoms who must receive antidepressant treatment organic diseases such as heart and brain diseases, brain trauma history of mental illness, use of psychoactive drugs such as drugs
  • •Severe liver and kidney dysfunction
  • •Pregnancy, lactation

研究组 & 干预措施

Ganoderma lucidum spore powder

Experimental

Oral administration of Ganoderma lucidum spore powder 4g per day ( 1 bag at a time, 2 times a day, 2g / bag ) for 90 days

干预措施: Ganoderma lucidum spore powder (Dietary Supplement)

placebo

Placebo Comparator

Oral ' placebo ' 4g per day ( 1 bag at a time, 2 times a day, 2g / bag ) for 90 days.

干预措施: placebo (Other)

结局指标

主要结局

Depression symptoms relieved

时间窗: Day0,Month3

hamilton depression rating scale relieved from 8-20 to ≤8

次要结局

  • Changes of intestinal microbial diversity in patients(Day0,Month3)

研究者

发起方
Ling Zhiqiang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ling Zhiqiang

Principal Investigator

Zhejiang Cancer Hospital

研究点 (1)

Loading locations...

相似试验